CXCR4-using HIV variants in a cohort of Black men who have sex with men: HIV Prevention Trials Network 061
I‐Ming Chen(Nanyang Technological University), Susan H. Eshleman(Johns Hopkins University), Kenneth H. Mayer(Miriam Hospital), Wei Huang(BD Biosciences (United States)), Sharon Mannheimer(Columbia University Irving Medical Center), Sam Griffith(Family Health International 360), Arne Frantzell(BD Biosciences (United States)), Sheldon D. Fields(Pennsylvania State University), Steven Shoptaw(University of California, Los Angeles), Geetha Beauchamp(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Beryl A. Koblin(New York Blood Center), Hyman Scott(UCLA Medical Center), Manya Magnus(Milken Institute), Carlos del Rı́o(Emory University), Vanessa Cummings(Johns Hopkins University), Hong‐Van Tieu(New York Blood Center), Darrell P. Wheeler(Loyola University Chicago), Matthew B. Connor(Infectious Disease Research Institute)
Cited by 1
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891